Peer-reviewedLicence not statedActa Pharmacologica Sinica
Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention
- 1Medical Research Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510515 China
- 2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center; Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060 China
Related
- Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives
- Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies.
- Target Discovery and Drug Intervention in Inflammatory Diseases： A Paradigm Shift from Mechanistic Dissection to Precision Therapy
- Epigenetic Rewiring of Enhancer–Promoter Interactions in Cancer: Mechanisms and Therapeutic Implications
- Chromatin remodeling in bone organoids: from epigenetic regulation to disease modeling and therapeutic translation.
BibTeX
@article{zhao2026epigenetic,
title = {{Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention}},
author = {Wei Zhao and Jing-xuan Pan},
journal = {Acta Pharmacologica Sinica},
year = {2026},
month = jun,
doi = {10.1038/s41401-026-01835-4},
url = {https://doi.org/10.1038/s41401-026-01835-4},
}
RIS
TY - JOUR
TI - Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention
AU - Wei Zhao
AU - Jing-xuan Pan
PY - 2026
DA - 2026/06/11
JO - Acta Pharmacologica Sinica
DO - 10.1038/s41401-026-01835-4
UR - https://doi.org/10.1038/s41401-026-01835-4
SN - 1671-4083
SN - 1745-7254
ER -